Erratum to "Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat" [Regulatory Peptides 151 (2008) 88-94] (DOI:10.1016/j.regpep.2008.10.004);Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat

Regulatory Peptides

Volumn 151, Issue 1-3, 2008, Pages 88-94

  Zhang, Yonggang ^a   Li, Yuguang ^a   Wei, Ruihong ^a   Wang, Zhijian ^b   Bu, Dingfang ^b   Zhao, Jing ^b   Pang, Yongzheng ^b   Tang, Chaoshu ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Adventitial fibroblasts; Collagen; GPR14; Peptide; Proliferation; Receptor; Vascular remodeling

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM CHANNEL; CELL RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NICARDIPINE; PROTEIN KINASE C; UNCLASSIFIED DRUG; URANTIDE; UROTENSIN II; UROTENSIN RECEPTOR; WORTMANNIN;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DNA SYNTHESIS; MALE; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TUNICA MEDIA;

RATTUS;

EID: 56249138931     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.11.005     Document Type: Erratum

References (41)

1. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A 95 (1998) 15803-15808
2. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
3. Balat A., Karakök M., Yilmaz K., and Kibar Y. Urotensin-II immunoreactivity in children with chronic glomerulonephritis. Ren Fail 29 (2007) 573-578
4. Segain J.P., Rolli-Derkinderen M., Gervois N., Raingeard de la Blétière D., Loirand G., and Pacaud P. Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J Immunol 179 (2007) 901-909
5. Bousette N., Patel L., Douglas S.A., Ohlstein E.H., and Giaid A. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 176 (2004) 117-123
6. Zhang Y.G., Chen Y.H., Ma C.Y., Qi Y.F., Pang Y.Z., and Tang C.S. Mitogenic effect of urotensin II on cells. Chin J Arterioscler 9 (2001) 14-16
7. Watanabe T., Takahashi K., Kanome T., Hongo S., Miyazaki A., Koba S., et al. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide. Hypertens Res 29 (2006) 821-831
8. Onan D., Pipolo L., Yang E., Hannan R.D., and Thomas W.G. Urotensin-II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol 18 (2004) 2344-2354
9. Watanabe T., Suguro T., Kanome T., Sakamoto Y., Kodate S., Hagiwara T., et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 46 (2005) 738-744
10. Suguro T., Watanabe T., Ban Y., Kodate S., Misaki A., Hirano T., et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 20 (2007) 211-217
11. Heringlake M., Kox T., Uzun O., Will B., Bahlmann L., Klaus S., et al. The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease. Regul Pept 121 (2004) 129-136
12. Douglas S.A., Tayara L., Ohlstein E.H., Halawa N., and Giaid A. Congestive heart failure and expression of myocardial urotensin II. Lancet 359 (2002) 1990-1997
13. Zhang Y.G., Li J.X., Cao J., Chen J., Yang J., Zhang Z.K., et al. Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium. Heart Vessels 16 (2002) 64-68
14. Zhang Y.G., Li Y.G., Liu B.G., Wei R.H., Wang D.M., Tan X.R., et al. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta Pharmacol Sin 28 (2007) 36-43
15. Tzanidis A., Hannan R.D., Thomas W.G., Onan D., Autelitano D.J., See F., et al. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res 93 (2003) 246-253
16. Sartore S., Chiavegato A., Faggin E., Franch R., Puato M., Ausoni S., et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89 (2001) 1111-1121
17. An S.J., Boyd R., Zhu M., Chapman A., Pimentel D.R., and Wang H.D. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc Res 75 (2007) 702-709
18. Lin L., Ding W.H., Jiang W., Zhang Y.G., Qi Y.F., Yuan W.J., et al. Urotensin-II activates l-arginine/nitric oxide pathway in isolated rat aortic adventitia. Peptides 25 (2004) 1977-1984
19. Haurani M.J., and Pagano P.J. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?. Cardiovasc Res 75 (2007) 679-689
20. Faber J.E., Yang N., and Xin X. Expression of alpha-adrenoceptor subtypes by smooth muscle cells and dventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298 (2001) 441-452
21. Jiang W., Jiang H.F., Cai D.Y., Pan C.S., Qi Y.F., Pang Y.Z., et al. Relationship between contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of rats in septic shock. Regul Pept 118 (2004) 199-208
22. Qi J.G., Du J.B., Tang X.Y., Li J., Wei B., and Tang C.S. The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart Vessels 19 (2004) 81-88
23. Itoh H., McMaster D., and Lederis K. Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur J Pharmacol 149 (1988) 61-66
24. Wolff A.A., Hines D.K., and Karliner J.S. Refined membrane preparations mask ischemic fall in myocardial beta-receptor density. Am J Physiol 257 (1989) H1032-1036
25. Jones L.R., and Besch Jr. H.R. Isolation of canine cardiac sarcolemmal vesicles. In: Schwartz A. (Ed). Methods in pharmacology (1984), Plenum Publishing Corporation, New York 1-12
26. Yu S.M., Tsai S.Y., Guh J.H., Ko F.N., Teng C.M., and Ou J.T. Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation 94 (1996) 547-554
27. Li Y.R. Biochemistry of extracellular mesenchyma and study methods. First edition (1988), People Health Publishing, Beijing 222-223
28. Matsushita M., Shichiri M., Fukai N., Ozawa N., Yoshimoto T., Takasu N., and Hirata Y. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144 (2003) 1825-1831
29. Marco J., Egido E.M., Hernández R., and Silvestre R.A. Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas. Peptides 29 (2008) 852-858
30. Watson A.M., Lambert G.W., Smith K.J., and May C.N. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42 (2003) 373-379
31. Xu C., Zarins C.K., Pannaraj P.S., Bassiouny H.S., and Glagov S. Hypercholesterolemia superimposed by experimental hypertension induces differential distribution of collagen and elastin. Arterioscler Thromb Vasc Biol 20 (2000) 2566-2572
32. Rakowski E., Hassan G.S., Dhanak D., Ohlstein E.H., Douglas S.A., and Giaid A. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker. J Mol Cell Cardiol 39 (2005) 785-791
33. Zhang Y.G., Qi Y.F., Xia C.F., Pang Y.Z., Yang J., Zhang Z.K., and Tang C.S. Stimulating proliferation of aorta smooth muscle cells of rat by rat urotensin II. Chin Pharmacol Bull 17 (2001) 155-157
34. Maguire J.J., Kuc R.E., Wiley K.E., Kleinz M.J., and Davenport A.P. Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 25 (2004) 1767-1774
35. Djordjevic T., BelAiba R.S., Bonello S., Pfeilschifter J., Hess J., and Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25 (2005) 519-525
36. Zhang Y.G., Li J., Li Y.G., and Wei R.H. Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta. J Hypertens 26 (2008) 1119-1126
37. Maiellaro K., and Taylor W.R. The role of the adventitia in vascular inflammation. Cardiovasc Res 75 (2007) 640-648
38. Xu F., Ji J., Li L., Chen R., and Hu W. Activation of adventitial fibroblasts contributes to the early development of atherosclerosis: a novel hypothesis that complements the "response-to-injury hypothesis" and the "inflammation hypothesis". Med Hypotheses 69 (2007) 908-912
39. Li L., Terry C.M., Blumenthal D.K., Kuji T., Masaki T., Kwan B.C., Zhuplatov I., Leypoldt J.K., and Cheung A.K. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dial Transplant 22 (2007) 3139-3146
40. Miller F.J. Adventitial fibroblasts. Backstage journeymen. Arterioscler Thromb Vasc Biol 21 (2001) 722-723
41. Krick S., Hänze J., Eul B., Savai R., Seay U., Grimminger F., et al. Hypoxiadriven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF- 1alpha and an autocrine angiotensin system. FASEB J 19 (2005) 857-859